SUPPRESSION OF THE NITRIC OXIDE PATHWAY IN METASTATIC RENAL CELL CARCINOMA PATIENTS RECEIVING VEGF-SIGNALING INHIBITORS

Therapies that target the vascular endothelial growth factor (VEGF) pathway cause hypertension but the mechanism remains unknown. This cross-sectional study tested the hypothesis that VEGF inhibition causes hypertension by suppressing VEGF-mediated vasodilatory pathways. Urine was collected from 80...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Robinson, Emily S., Khankin, Eliyahu V., Choueiri, Toni K., Dhawan, Mallika D., Rogers, Miranda J., Karumanchi, S. Ananth, Humphreys, Benjamin D.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2010
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3078049/
https://ncbi.nlm.nih.gov/pubmed/20956731
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/HYPERTENSIONAHA.110.160481
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares